The Business Value of Digital Health
This article explores what pharmaceutical companies are doing with to attain or assess their digital assets in order to add value to their portfolios, and overall business. Executives from pharma and consultants provide their input into what is currently shifting in digital priorities, as well as what is on the horizon.

Digital Health and the Future of Patient Adherence
For patients, physicians and payers, it is vital that medication compliance is ensured to manage diseases and conditions. And it is becoming more incumbent on pharmaceutical companies to invest in technologies that help patients adhere to their medication to deliver the desired outcomes. This article tackles the digital landscape in regard to patient adherenece.

Eight Digital Health Technologies to Watch
PE Editors chose 8 technologies—from intelligent inhalers to wireless EKGs—that pharm execs should know about for potential impact or future uses.

When KOLS Are No Longer Enough: Finding Digital Opinion Influencers
Gregg Fisher, CEO, The Stem, a digital consultancy in the pharma industry
Pharma firms have long recognized the power of Key Opinion Leaders (KOLs). The problem, however, is that growing number of patients are acquiring their information in the online world – and many KOLs are not DOIs, or Digital Opinion Influencers. This article provides best practices for finding DOIs and creating relationships with them, with an eye on compliance rules.